p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation

• Published in: Science signaling Vol. 11; no. 521
• Main Authors: Zheng, Tingting, Zhao, Weiheng, Li, Hongjin, Xiao, Shuxiu, Hu, Ran, Han, Miaomiao, Liu, Heng, Liu, Yeqiang, Otsu, Kinya, Liu, Xinguang, Huang, Gonghua
• Format: Journal Article
• Language: English
• Published: United States 13.03.2018
• ISSN: 1937-9145
• DOI: 10.1126/scisignal.aao1685

Dendritic cells (DCs) contribute to psoriasis pathogenesis. In a mouse model of imiquimod-induced psoriasiform skin inflammation, we found that p38α activity in Langerhans cells (LCs), a skin-resident subset of DCs, promoted the generation of T cells that produce IL-17, a proinflammatory cytokine that is implicated in autoimmune disease. Deletion of p38α in LCs, but not in other skin or circulating DC subsets or T cells, decreased T cell-mediated psoriasiform skin inflammation in mice. The activity of p38α in LCs specifically promoted IL-17 production from γδ and CD4 T cells by increasing the abundance of IL-23 and IL-6, two cytokines that stimulate IL-17 secretion. Inhibition of p38 activity through either pharmacological inhibition or genetic deletion also reduced the severity of established psoriasiform skin inflammation. Together, our findings indicate a critical role for p38α signaling in LCs in promoting inflammatory responses in the skin and suggest that targeting p38α signaling in LCs may offer an effective therapeutic approach to treat psoriasis.